Cargando…
Genetic overlap between idiopathic pulmonary fibrosis and COVID−19
Coronavirus disease 2019 (COVID-19) is an infectious disease potentially leading to long lasting respiratory symptoms and has resulted in over 4 million deaths worldwide. Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease (ILD) characterised by an aberrant response to alveola...
Autores principales: | Allen, Richard J, Guillen-Guio, Beatriz, Croot, Emma, Kraven, Luke M, Moss, Samuel, Stewart, Iain, Jenkins, R Gisli, Wain, Louise V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130756/ https://www.ncbi.nlm.nih.gov/pubmed/35595312 http://dx.doi.org/10.1183/13993003.03132-2021 |
Ejemplares similares
-
Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension
por: Parcesepe, Gina, et al.
Publicado: (2023) -
The Use of Genetic Information to Define Idiopathic Pulmonary Fibrosis in UK Biobank
por: Leavy, Olivia C., et al.
Publicado: (2023) -
Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk
por: Mohammadi-Nejad, Ali-Reza, et al.
Publicado: (2022) -
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity
por: Fadista, João, et al.
Publicado: (2021) -
Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing
por: Lorenzo-Salazar, Jose M., et al.
Publicado: (2019)